Table 5.
Outcome | Unadjusted | Adjusted* | ||
---|---|---|---|---|
Hazard Ratio (95% CI) |
P-value | Hazard Ratio (95% CI) |
P-value | |
Mortality or Hospitalization | 1.27 (1.14, 1.41) | <.001 | 1.14 (1.01, 1.30) | 0.033 |
All-cause Mortality | 1.35 (1.10, 1.66) | 0.004 | 0.97 (0.78, 1.2) | 0.80 |
CV Mortality or HF Hospitalization | 1.52 (1.31, 1.77) | <0.001 | 1.08 (0.90, 1.30) | 0.41 |
Adjustment variables:
All-Cause Mortality/Hospitalization: peak VO2, KCCQ stability score, BUN, country, ejection fraction, sex, beta blocker dose, mitral regurgitation grade, ventricular conduction.
All-Cause Mortality: Baseline CPX test duration, creatinine, body mass index, sex, loop diuretic dose, left ventricular ejection fraction, canadian cardiovascular society anginal score, ventricular conduction.
CV Mortality/HF Hospitalization: Loop diuretic dose, ejection fraction, mitral regurgitation grade, ventricular conduction, KCCQ symptom stability score, BUN, race, sex, age.